Chung-Yuan Mou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Top Venues

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Zih-An Chen, Cheng-Hsun Wu, Si-Han Wu, Chiung-Yin Huang, Chung-Yuan Mou, Kuo-Chen Wei, Yun Yen, I-Ting Chien, Sabiha Runa, Yi-Ping Chen, Peilin Chen
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS nano 18 (20) (2024)
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma. ACS applied materials & interfaces (2024)
Zih-An Chen, Cheng-Hsun Wu, Si-Han Wu, Chiung-Yin Huang, Chung-Yuan Mou, Kuo-Chen Wei, Yun Yen, I-Ting Chien, Sabiha Runa, Yi-Ping Chen, Peilin Chen
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS nano 18 (20) (2024)
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma. ACS applied materials & interfaces 16 (17) (2024)
Zih-An Chen, Cheng-Hsun Wu, Si-Han Wu, Chiung-Yin Huang, Chung-Yuan Mou, Kuo-Chen Wei, Yun Yen, I-Ting Chien, Sabiha Runa, Yi-Ping Chen, Peilin Chen
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS nano 18 (20) (2024)
Zih-An Chen, Cheng-Hsun Wu, Si-Han Wu, Chiung-Yin Huang, Chung-Yuan Mou, Kuo-Chen Wei, Yun Yen, I-Ting Chien, Sabiha Runa, Yi-Ping Chen, Peilin Chen
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS nano (2024)
Zih-An Chen, Cheng-Hsun Wu, Si-Han Wu, Chiung-Yin Huang, Chung-Yuan Mou, Kuo-Chen Wei, Yun Yen, I-Ting Chien, Sabiha Runa, Yi-Ping Chen, Peilin Chen
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier. ACS nano 18 (20) (2024)
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma. ACS applied materials & interfaces 16 (17) (2024)
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma. ACS applied materials & interfaces 16 (17) (2024)
Jingling Yang, Geng-Sheng Lin, Chung-Yuan Mou, Kuo-Lun Tung
Mesoporous Silica Thin Membrane with Tunable Pore Size for Ultrahigh Permeation and Precise Molecular Separation. ACS applied materials & interfaces 12 (6) (2020)
Yi-Ping Chen, Li Xu, Tao-Wei Tang, Cheuh-Hsuan Chen, Quan-Hong Zheng, Tsang-Pai Liu, Chung-Yuan Mou, Cheng-Hsun Wu, Si-Han Wu
STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer. ACS applied materials & interfaces 12 (51) (2020)
Rong-Lin Zhang, Feby Wijaya Pratiwi, Bi-Chang Chen, Peilin Chen, Si-Han Wu, Chung-Yuan Mou
Simultaneous Single-Particle Tracking and Dynamic pH Sensing Reveal Lysosome-Targetable Mesoporous Silica Nanoparticle Pathways. ACS applied materials & interfaces 12 (38) (2020)
Ping-Hsing Tsai, Mong-Lien Wang, Jen-Hsuan Chang, Aliaksandr A Yarmishyn, Phan Nguyen Nhi Nguyen, Wei Chen, Yueh Chien, Teh-Ia Huo, Chung-Yuan Mou, Shih-Hwa Chiou
Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells. ACS applied materials & interfaces 11 (22) (2019)
Zih-An Chen, Si-Han Wu, Peilin Chen, Yi-Ping Chen, Chung-Yuan Mou
Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes. ACS applied materials & interfaces 11 (5) (2019)
Cheng-Shun Cheng, Tsang-Pai Liu, Fan-Ching Chien, Chung-Yuan Mou, Si-Han Wu, Yi-Ping Chen
Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth. ACS applied materials & interfaces 11 (17) (2019)